Home Local News Covid shots made Moderna biotech’s biggest star, but what now?

Covid shots made Moderna biotech’s biggest star, but what now?

53
0

What does a breakout company like Moderna do for an encore? More than a decade after its founding, the Cambridge biotech rolled out its first commercial product last year. And what a debut it was: a cutting-edge COVID-19 vaccine that helped to save thousands ― if not millions ― of lives around the world.

It was also a massive moneymaker for Moderna, which up until then had been unprofitable. With more than $38 billion in total COVID-19 vaccine sales expected by the end of this year ― many of the doses paid for by governments ― investors are wondering what the company plans to do with that windfall. Despite Moderna’s spectacular success, the question of what’s next looms large, and the pressure is on to avoid becoming a one-hit wonder.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED



This article is first published on Source link

Previous articleDenver’s e-bike rebates are already gaining traction with residents
Next article80-1 longshot Rich Strike stuns in winning 148th Kentucky Derby